An expert opinion on esophageal cancer therapy

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.2, 2011-02, pp. : 225-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Modality Therapy of Esophageal Cancer

By Juergens Rosalyn A. Forastiere Arlene

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 851-861

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Patterns of recurrence after trimodality therapy for esophageal cancer

By Dorth Jennifer A. Pura John A. Palta Manisha Willett Christopher G. Uronis Hope E. D'Amico Thomas A. Czito Brian G.

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2099-2105

Blackwell Publishing

Access to resources Recommend Favorite

Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-01 ,pp. : 509-521

Bentham Science Publishers

Access to resources Recommend Favorite

microRNAs and Esophageal Cancer - Implications for Pathogenesis and Therapy

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1211-1226

Bentham Science Publishers

Access to resources Recommend Favorite

Treating arrhythmias: an expert opinion

By Dagres Nikolaos Sommer Philipp Anastasiou-Nana Maria Hindricks Gerhard

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1359-1367

Informa Healthcare

Access to resources Recommend Favorite